tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cathie Wood Starts This Volatile Week with $13M Buy and a Key Sell-Off

Cathie Wood Starts This Volatile Week with $13M Buy and a Key Sell-Off

Popular investor Cathie Wood’s ARK Invest made some interesting trade moves on Monday, July 7. As per the daily trades published by ARK, Wood continued to add more shares of gene-editing firm Beam Therapeutics (BEAM) and reduce its stake in online gaming company Roblox (RBLX).

Elevate Your Investing Strategy:

Wood Continues to Accumulate BEAM Stock

As per the daily trade disclosure, ARK snapped up over 659,000 shares of Beam Therapeutics across two ETFs — ARK Innovation ETF (ARKK) and ARK Genomic Revolution ETF (ARKG) — spending more than $13.2 million. Earlier this week, Wood bought an additional 28,743 shares of Beam Therapeutics for a total of $571,410. 

The firm has been steadily increasing its stake in Beam over the past week, showing clear confidence in the biotech’s CRISPR-based therapies and broader gene-editing potential.

Is BEAM a Good Stock to Buy?

Analysts share similar optimism about Beam Therapeutics as Cathie Wood does. On TipRanks, BEAM stock has a Strong Buy consensus rating based on 11 Buys and two Hold ratings. Also, the average Beam Therapeutics price target of $45 implies a massive 134.6% upside potential from current levels. Year-to-date, BEAM stock has lost 22.7%.

See more BEAM analyst ratings

Wood Trims Holdings in RBLX Stock

ARK Invest continued to pare down its stake in Roblox on Monday, selling 31,416 shares worth approximately $3.25 million. That adds to the selling seen last week, when ARK sold 26,877 shares of Roblox on July 2.

Interestingly, Roblox stock rose 4% on Monday, fueled by growing investor optimism around the platform’s long-term potential.

What is Roblox’s Price Target?

According to TipRanks, Wall Street has a Moderate Buy consensus rating on RBLX stock, based on 15 Buys, four Holds, and two Sells assigned in the last three months. The average Roblox stock price target of $87.43 implies a 18.87% upside potential.

See more RBLX analyst ratings

Disclaimer & DisclosureReport an Issue

1